Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder

NCT00514865 is registered in ClinicalTrials.gov with Ono Pharma USA Inc as lead sponsor.

NCT NCT00514865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00514865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
Lead sponsor
Ono Pharma USA Inc
Phase
Phase 2
Overall status
Completed
Start date
June 13, 2007
Completion date
June 30, 2008
Enrollment
278 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder